Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing
Brian R. Shy(University of California, San Francisco), Alexander Marson(Gladstone Institutes), Murad R. Mamedov(Gladstone Institutes), Yan Yi Chen(Gladstone Institutes), Vivasvan S. Vykunta(Gladstone Institutes), Justin Eyquem(Gladstone Institutes), David N. Nguyen(University of California, San Francisco), Franziska Blaeschke(German Cancer Research Center), Jonathan H. Esensten(Memorial Sloan Kettering Cancer Center), Alvin Ha(Gladstone Institutes), Alexis Talbot(Gladstone Institutes), Theodore L. Roth(University of California, San Francisco), Thomas Martin(University of California, San Francisco), Shane Vedova(Gladstone Institutes), Lumeng Ye, Jing-Yi Chung(Gladstone Institutes), Hong Li(Van Andel Institute), Jeffrey L. Wolf(City College of San Francisco)
Cited by 16
Related Papers
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
CD28 Costimulation: From Mechanism to Therapy
|Immunity|2016|936
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
|Cancer Cell|2022|347
Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
|Nature Biotechnology|2019|324